Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

1. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity

   Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani +11

   MaqolaChemotherapy-induced cardiotoxicity and mitigationInnovative medicine of Kuban20231 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.001614

2. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)

   Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15

   MaqolaDiabetes Treatment and ManagementInnovative medicine of Kuban20241 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.001048